The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChamberlin Plc Regulatory News (CMH)

  • This share is currently suspended. It was suspended at a price of 1.18

Share Price Information for Chamberlin Plc (CMH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.18
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.18
CMH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

24 Feb 2010 07:00

RNS Number : 5796H
Chamberlin PLC
24 February 2010
 



24 February 2010

Chamberlin plc

("Chamberlin" or "the Company")

 

Director / PDMR Shareholding

 

 

The Company has today announced that the Board has approved the grant of options to the Executive Directors under the Chamberlin Share Option Plan (the "SOP"). At the same time the Directors will surrender all of their existing share options granted under the SOP, The Chamberlin & Hill Approved Share Plan (the "Approved Plan") and the Chamberlin & Hill Unapproved Share Plan (the "Unapproved Plan"). Tim Hair will also surrender some of his existing share options granted under The Chamberlin Performance Share Plan (the "PSP").

 

The Directors have been granted the following options:

 

Director

Number of options surrendered

Number of options retained under PSP*

Number of parallel options awarded under SOP*

Number of new options awarded under SOP

Total number of options

Tim Hair

Mark Bache

Adam Vicary

576,987

250,971

51,000

193,935

152,367

99,222

193,935

152,367

99,222

698,584

293,892

49,531

892,519

446,259

148,753

 

* The options retained under the PSP will be subject to the existing performance criteria as defined by the scheme. In the event that these options fail to vest, those SOP options awarded in parallel to the PSP scheme will become exercisable, subject to the performance conditions below. In the event that the PSP options are exercised the equivalent number of SOP options will be cancelled.

 

Excluding the parallel grant of SOP options, which is on an either/or basis with existing PSP options, in total 878,958 options are being surrendered and 1,042,007 new options issued. It remains the Company's intention to restrict the actual dilution of existing ordinary share capital to no more than 10% through the use of market purchased shares or cash in lieu of the exercise of options, in so far as this is prudently possible.

 

The SOP options are exercisable at a price of 52.8 pence each, based on the average closing mid-market price over the past 30 trading days, at any time between 23 February 2013 and 23 February 2020. They will vest subject to a TSR performance equivalent to achieving minimum share price of 100 pence on a theoretical no dividends basis (at which one third of the options will vest) up to a maximum price equivalent to 180p on the same basis at which all SOP options will vest, with vesting calculated on a straight line basis between these points. Performance will be tested over a period of three years from 23 February 2010.

 

The options surrendered by Tim Hair, Mark Bache and Adam Vicary were cancelled on 23 February 2010.

 

For further information:

 

Chamberlin plc T: 01922 707100

Tom Brown, Chairman

Tim Hair, Chief Executive

 

Charles Stanley Securities T: 020 7149 6000

Nominated Adviser

Russell Cook/Jen Boorer

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSTJMLTMBMTBLM
Date   Source Headline
5th May 20221:13 pmRNSSale and Leaseback of RDC Property
25th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20222:30 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSHolding(s) in Company
21st Feb 20227:00 amRNSHolding(s) in Company
18th Feb 202210:30 amRNSResult of General Meeting and Total Voting Rights
2nd Feb 20227:00 amRNSProposed Placing and Subscription and Notice of GM
5th Jan 202212:15 pmRNSResult of AGM
4th Jan 20227:00 amRNSContract Award
21st Dec 20217:00 amRNSHalf-year Report
30th Nov 202111:01 amRNSFinal Results
16th Sep 20217:00 amRNSPublication of Audited Accounts and Trading Update
30th Jul 20217:00 amRNSHolding(s) in Company
9th Jul 20217:00 amRNSOperational Update
8th Jul 20217:00 amRNSHolding(s) in Company
8th Jun 20212:45 pmRNSResult of AGM
1st Jun 20217:00 amRNSDirectorate Change
28th May 20218:00 amRNSDirectorate Change
19th May 202111:05 amRNSSecond Price Monitoring Extn
19th May 202111:00 amRNSPrice Monitoring Extension
19th May 20219:05 amRNSSecond Price Monitoring Extn
19th May 20219:00 amRNSPrice Monitoring Extension
19th May 20217:00 amRNSOperational Update
14th May 20212:15 pmRNSChange of Accounting Reference Date
14th May 20217:00 amRNSGrant of Options
11th May 20214:41 pmRNSSecond Price Monitoring Extn
11th May 20214:36 pmRNSPrice Monitoring Extension
11th May 20212:05 pmRNSSecond Price Monitoring Extn
11th May 20212:00 pmRNSPrice Monitoring Extension
11th May 202111:05 amRNSSecond Price Monitoring Extn
11th May 202111:00 amRNSPrice Monitoring Extension
11th May 20219:05 amRNSSecond Price Monitoring Extn
11th May 20219:00 amRNSPrice Monitoring Extension
7th May 20217:00 amRNSDirectorate Change
5th May 20212:06 pmRNSSecond Price Monitoring Extn
5th May 20212:00 pmRNSPrice Monitoring Extension
27th Apr 20217:00 amRNSDirectorate Change
20th Apr 20214:10 pmEQSHardman & Co Research: Chamberlin (CMH): Getting back into shape
16th Apr 20217:30 amRNSRestoration - Chamberlin Plc
16th Apr 20217:00 amRNSHalf-year Report
16th Apr 20217:00 amRNSFinal Results
13th Apr 20215:04 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSFurther re Publication of Accounts
1st Apr 20217:00 amRNSTotal Voting Rights
30th Mar 20215:55 pmRNSHolding(s) in Company
30th Mar 20214:03 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSPlacing, Subscription and Trading Update
11th Mar 20215:21 pmRNSHolding(s) in Company
10th Mar 202110:41 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.